about
Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple IntegrinsNanotheranostics for personalized medicineAdvance of molecular imaging technology and targeted imaging agent in imaging and therapyIn vivo imaging of therapy-induced anti-cancer immune responses in humans.Radiolabeled cyclic RGD peptides as radiotracers for tumor imagingQuantitative analysis and comparison study of [18F]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [68Ga]Ga-NOTA-PRGD2 using a reference tissue modelTargeting activated hepatic stellate cells (aHSCs) for liver fibrosis imagingApplication of (68)Ga-PRGD2 PET/CT for αvβ3-integrin imaging of myocardial infarction and stroke.Comparison of 18F-AIF-NOTA-PRGD2 and 18F-FDG uptake in lymph node metastasis of differentiated thyroid cancer.Current and future intraoperative imaging strategies to increase radical resection rates in pancreatic cancer surgery.Near-infrared fluorescence imaging of both colorectal cancer and ureters using a low-dose integrin targeted probe.Image guided biodistribution and pharmacokinetic studies of theranostics.Integrin Targeted Imaging and Therapy.Targeted nanoprobes reveal early time point kinetics in vivo by time-resolved MRINew Methods for Labeling RGD Peptides with Bromine-76.Transforming a Targeted Porphyrin Theranostic Agent into a PET Imaging Probe for Cancer.Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in micePET Imaging of Integrin Positive Tumors Using F Labeled Knottin Peptides.Nanoparticles labeled with positron emitting nuclides: advantages, methods, and applications.How Does the Patient Benefit from Clinical PET?The efficient synthesis and biological evaluation of novel bi-functionalized sarcophagine for (64)cu radiopharmaceuticals.Longitudinal PET imaging of doxorubicin-induced cell death with 18F-Annexin V.Quantitative analysis and parametric imaging of 18F-labeled monomeric and dimeric RGD peptides using compartment model.PET Tracers for Clinical Imaging of Breast Cancer.Positron emission tomography imaging of tumor angiogenesis and monitoring of antiangiogenic efficacy using the novel tetrameric peptide probe 64Cu-cyclam-RAFT-c(-RGDfK-)4.Lewis acid-assisted isotopic 18F-19F exchange in BODIPY dyes: facile generation of positron emission tomography/fluorescence dual modality agents for tumor imagingPhotosensitizer-conjugated silica-coated gold nanoclusters for fluorescence imaging-guided photodynamic therapy.First experience of 18F-alfatide in lung cancer patients using a new lyophilized kit for rapid radiofluorinationPET imaging of inflammation biomarkers.Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Longitudinal PET imaging of muscular inflammation using 18F-DPA-714 and 18F-Alfatide II and differentiation with tumors.RGD-based PET tracers for imaging receptor integrin αv β3 expression.Recommendations for the clinical and radiological evaluation of response to treatment in metastatic renal cell cancer.Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT.Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation.Evaluation of neurotensin receptor 1 as a potential imaging target in pancreatic ductal adenocarcinoma.Integrin Ligands with α/β-Hybrid Peptide Structure: Design, Bioactivity, and Conformational Aspects.Comparison of biological properties of 99mTc-labeled cyclic RGD Peptide trimer and dimer useful as SPECT radiotracers for tumor imaging.Design, synthesis and biological evaluation of novel dimeric and tetrameric cRGD-paclitaxel conjugates for integrin-assisted drug delivery.MicroPET imaging of tumor angiogenesis and monitoring on antiangiogenic therapy with an (18)F labeled RGD-based probe in SKOV-3 xenograft-bearing mice.
P2860
Q26801806-87ACA5EA-AB19-4E03-8BE9-6688A180669DQ26851449-22C93EF5-FECF-496B-A04E-3723922E976FQ26851887-EB9E8959-84A6-4599-97CE-41437D933C2AQ27693338-AC6E9A46-F587-44A5-A4F9-93BD83643430Q28072021-0B79A0DD-6775-4358-918F-3FF7D44C6BB8Q28729872-C43A7DCC-557C-4AF4-B45E-3E907B92B280Q30395463-47AA53AD-8368-40BA-A390-B873FC532321Q30832796-10DA4D2F-3BC2-446F-941D-E6902AF880AAQ33793550-7CD218EA-8FBD-444C-8EDC-780BA38B85A5Q34009539-F419A889-4F6A-45DF-8200-9DF97F9E75DAQ34028690-1225882D-6715-4CBE-BA8B-B130844D8AD3Q34506838-698CDDCA-67AE-4D77-80A9-309D5CE80266Q34786949-14301EA2-6F4A-4294-9376-32D52CC44758Q34974123-50BC0620-A10F-4B65-9B96-1C1AA96EF584Q35224462-7C50BD47-BFD1-40DF-B022-0A33541D702CQ35224469-A6E70431-D0AF-444E-B09F-AC7EC48549B3Q35629161-D8435E86-9711-41A1-920D-76E5998BD5A1Q35641937-E1284B6D-56A6-4245-BBE6-C251F6055AD3Q35897573-808E9D9D-281B-476E-BBDD-E428CC126755Q35988082-4D328D3A-62C0-4BE1-8086-7510C4B9B3EDQ36052972-676F3BCD-B936-432E-94EE-18DEB5A97373Q36069595-D12FDC71-6A3E-4DB5-9488-D18B4AAF4DF0Q36107186-B1535826-7BCB-49E5-8827-5C6093BF3ECBQ36221080-E4D5E0E8-BC0E-4FD6-B68A-72EE9F907EE2Q36394255-47BEC2C4-6BC7-4255-843E-19466B7CD633Q36663342-46E71666-55DA-4612-AF9F-471436F72D6EQ36820918-22AED3F3-4748-48FD-A62E-30E75CE5D845Q36931413-1C71249E-C462-4B68-8E6C-796DC45A80CDQ36997603-F4737913-261C-4AF7-9065-A383653DA15EQ37236103-D5E8FB55-0847-4B44-9340-E8DDC64519A6Q37663675-06A8EBFF-2FEA-4947-90BF-9BB956A640CEQ38166986-7E5A9268-FB53-45B7-AA2A-C6861C930CAAQ38171376-261487BB-3117-421F-9C62-F60C1F99D38BQ38440214-29184F2A-9F26-45E7-BAEA-50DB80B38E66Q38501776-5C8FB67F-8D10-49BC-AF3B-EFA45635A3B7Q38680000-832E0F1A-E862-4C68-AE95-EBACDA216974Q38700087-98B63CC1-1480-4D12-86C4-88322DDB0D75Q38738606-94EC8A96-A0DA-4F1D-9B89-183068C6CFBCQ38864088-5C61776E-6405-46DB-9ACD-BFBE3C5FF114Q38929240-62CB3F73-1151-4254-9793-87960C452458
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
PET Imaging of Integrin αVβ3 Expression
@en
PET Imaging of Integrin αVβ3 Expression
@nl
type
label
PET Imaging of Integrin αVβ3 Expression
@en
PET Imaging of Integrin αVβ3 Expression
@nl
prefLabel
PET Imaging of Integrin αVβ3 Expression
@en
PET Imaging of Integrin αVβ3 Expression
@nl
P2093
P2860
P356
P1433
P1476
PET Imaging of Integrin αVβ3 Expression
@en
P2093
Ambros J Beer
Hans-Jürgen Wester
Horst Kessler
Markus Schwaiger
P2860
P356
10.7150/THNO/V01P0048
P577
2011-01-17T00:00:00Z